Long Term Survivors in Ovarian Cancer
NCT03128294 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 69
Last updated 2024-04-19
Summary
In this study the investigators would like to explore the patient and tumour characteristics of long-term survivors of ovarian cancer (\>10 years). Indentifiying the characteristics of long-term survivors not only helps find prognostic factors for survival but may aid in generating hypotheses for novel therapeutic strategies.
Conditions
Interventions
- OTHER
-
Retrospective, cross-sectional descriptive analysis
This study is a retrospective, cross-sectional descriptive analysis, and concerns the extraction of data from anonymised patient files. A database will be constructed and descriptive statistics will be used to summarise the data.
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Principal Investigators
-
A.K.L. Reyners, MD, PhD · University Medical Center Groningen
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-31
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
NCT01218490 ·Status: SUSPENDED ·Phase: PHASE3
-
Prognostic and Predictive Biomarkers in Ovarian Cancers
NCT03010124 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260 ·Status: COMPLETED
-
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NCT03418844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma
NCT03302884 ·Status: UNKNOWN ·Phase: NA
-
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
NCT06445621 ·Status: RECRUITING
-
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
NCT02323568 ·Status: COMPLETED ·Phase: NA
-
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
NCT06969833 ·Status: RECRUITING ·Phase: NA
-
DOD Long-Term Survivors of Ovarian Cancer
NCT02321735 ·Status: UNKNOWN ·Phase: NA
-
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
NCT03491033 ·Status: COMPLETED
-
SEQUENTIAL PROFILING OF TUMOR-DERIVED CIRCULATING CELL-FREE DNA (ctDNA) IN ADVANCED OVARIAN CANCER PATIENTS
NCT06071286 ·Status: RECRUITING ·Phase: NA
-
Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments
NCT06025045 ·Status: UNKNOWN
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Predictive Factors of Chemoresistance in Ovarian Cancer
NCT02878122 ·Status: COMPLETED
-
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
NCT00897806 ·Status: TERMINATED
-
Survivorship Care Planning in Improving Quality of Life in Survivors of Ovarian Cancer
NCT02082470 ·Status: COMPLETED ·Phase: NA
-
Women Surviving Ovarian Cancer
NCT00596349 ·Status: COMPLETED
-
Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer
NCT01462890 ·Status: COMPLETED ·Phase: PHASE3
-
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00288275 ·Status: TERMINATED
-
Quality-of-Life Assessment in Patients With Ovarian Cancer
NCT00003772 ·Status: COMPLETED
-
Pharmacogenomics of Paclitaxel in Ovarian Cancer
NCT00415207 ·Status: COMPLETED